Abstract:In-silico identification of potential target genes for disease is an essential aspect of drug target discovery. Recent studies suggest that successful targets can be found through by leveraging genetic, genomic and protein interaction information. Here, we systematically tested the ability of 12 varied algorithms, based on network propagation, to identify genes that have been targeted by any drug, on gene-disease data from 22 common non-cancerous diseases in OpenTargets. We considered two biological networks, six performance metrics and compared two types of input gene-disease association scores. The impact of the design factors in performance was quantified through additive explanatory models. Standard cross-validation led to over-optimistic performance estimates due to the presence of protein complexes. In order to obtain realistic estimates, we introduced two novel protein complex-aware cross-validation schemes. When seeding biological networks with known drug targets, machine learning and diffusion-based methods found around 2-4 true targets within the top 20 suggestions. Seeding the networks with genes associated to disease by genetics decreased performance below 1 true hit on average. The use of a larger network, although noisier, improved overall performance. We conclude that diffusion-based prioritisers and machine learning applied to diffusion-based features are suited for drug discovery in practice and improve over simpler neighbour-voting methods. We also demonstrate the large impact of choosing an adequate validation strategy and the definition of seed disease genes.The use of biological network data has proven its effectiveness in many areas from computational biology. Networks consist of nodes, usually genes or proteins, and edges that connect pairs of nodes, representing information such as physical interactions, regulatory roles or co-occurrence. In order to find new candidate nodes for a given biological property, the so-called network propagation algorithms start from the set of known nodes with that property and leverage the connections from the biological network to make predictions. Here, we assess the performance of several network propagation algorithms to find sensible gene targets for 22 common non-cancerous diseases, i.e. those that have been found promising enough to start the clinical trials with any compound. We focus on obtaining performance metrics that reflect a practical scenario in drug development where only a small set of genes can be essayed. We found that the presence of protein complexes biased the performance estimates, leading to over-optimistic conclusions, and introduced two novel strategies to address it. Our results support that network propagation is still a viable approach to find drug targets, but that special care needs to be put on the validation strategy. Algorithms benefitted from the use of a larger -although noisier- network and of direct evidence data, rather than indirect genetic associations to disease.

Relation-weighted Link Prediction for Disease Gene Identification

Towards Identification of Human Disease Phenotype-Genotype Association via a Network-Module Based Method

A knowledge graph-based disease-gene prediction system using multi-relational graph convolution networks

End-to-end interpretable disease–gene association prediction

GATher: Graph Attention Based Predictions of Gene-Disease Links

A knowledge graph approach to predict and interpret disease-causing gene interactions

Ensemble decision of local similarity indices on the biological network for disease related gene prediction

Recent Advances in Network-based Methods for Disease Gene Prediction

A deep learning framework for predicting disease-gene associations with functional modules and graph augmentation

Benchmarking network propagation methods for disease gene identification

KDGene: knowledge graph completion for disease gene prediction using interactional tensor decomposition

Knowledge Graph Completion based on Tensor Decomposition for Disease Gene Prediction

A probabilistic knowledge graph for target identification

Towards Probabilistic Generative Models Harnessing Graph Neural Networks for Disease-Gene Prediction

Identifying Candidate Gene–Disease Associations via Graph Neural Networks

Graph Based Link Prediction between Human Phenotypes and Genes

Heterogeneous Network Embedding Enabling Accurate Disease Association Predictions

Gndd: A Graph Neural Network-Based Method For Drug-Disease Association Prediction

A network-based machine-learning framework to identify both functional modules and disease genes

Pathogenic gene prediction based on network embedding

DGLinker: flexible knowledge-graph prediction of disease–gene associations